[go: up one dir, main page]

GR3019970T3 - Pharmaceutical compositions for use in treating aids - Google Patents

Pharmaceutical compositions for use in treating aids

Info

Publication number
GR3019970T3
GR3019970T3 GR960401345T GR960401345T GR3019970T3 GR 3019970 T3 GR3019970 T3 GR 3019970T3 GR 960401345 T GR960401345 T GR 960401345T GR 960401345 T GR960401345 T GR 960401345T GR 3019970 T3 GR3019970 T3 GR 3019970T3
Authority
GR
Greece
Prior art keywords
image
pharmaceutical compositions
treating aids
bri
aliphatic
Prior art date
Application number
GR960401345T
Other languages
English (en)
Inventor
Stanislaw R Burzynski
Original Assignee
Stanislaw R Burzynski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanislaw R Burzynski filed Critical Stanislaw R Burzynski
Publication of GR3019970T3 publication Critical patent/GR3019970T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
GR960401345T 1990-09-04 1996-05-20 Pharmaceutical compositions for use in treating aids GR3019970T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/577,464 US5089508A (en) 1990-09-04 1990-09-04 Methods for treating aids
PCT/US1991/005977 WO1992004027A1 (en) 1990-09-04 1991-08-21 Pharmaceutical compositions for use in treating aids

Publications (1)

Publication Number Publication Date
GR3019970T3 true GR3019970T3 (en) 1996-08-31

Family

ID=24308852

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960401345T GR3019970T3 (en) 1990-09-04 1996-05-20 Pharmaceutical compositions for use in treating aids

Country Status (11)

Country Link
US (1) US5089508A (el)
EP (1) EP0500905B1 (el)
AT (1) ATE135217T1 (el)
AU (1) AU638869B2 (el)
DE (1) DE69117923T2 (el)
DK (1) DK0500905T3 (el)
ES (1) ES2084181T3 (el)
GR (1) GR3019970T3 (el)
SG (1) SG81889A1 (el)
WO (1) WO1992004027A1 (el)
ZA (1) ZA916977B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244922A (en) * 1990-09-04 1993-09-14 Burzynski Stanislaw R Methods for treating viral infections
DE59101214D1 (de) * 1991-07-15 1994-04-21 Artesan Pharma Gmbh Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich.
US5646182A (en) * 1992-06-15 1997-07-08 Burzynski; Stanislaw R. Methods for treating autoimmune diseases
DE4320201A1 (de) * 1993-06-18 1995-01-12 Asta Medica Ag Verwendung von Cetrorelix und weiteren Nona- und Dekapeptiden zur Herstellung eines Arzneimittels zur Bekämpfung von Aids und zur Wachstumsstimulation
ATE310505T1 (de) * 1996-05-14 2005-12-15 Stanislaw R Burzynski Liposomale antineoplaston therapie mit bemerkenswert verbesserter antineoplastischer aktivität
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470970A (en) * 1981-07-02 1984-09-11 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4558057A (en) * 1981-12-15 1985-12-10 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4427684A (en) * 1982-09-24 1984-01-24 Ores Richard O Treatment and prevention of infection with herpes simplex and related viruses
EP0452765B1 (en) * 1985-09-11 1999-10-20 Btg International Limited Pharmaceutical composition and medical uses of dioxopiperidine derivatives, especially as immune response potentiators, antiviral and antibacterial agents
US4705796A (en) * 1986-08-25 1987-11-10 Stereochemical Genetics, Inc. Use of 3-N-phenylacetylamino-2,6-piperidinedione for treatment of neuropsychiatric disorders
DE3814549A1 (de) * 1987-10-30 1989-05-18 Bayer Ag N-substituierte derivate von 1-desoxynojirimycin und 1-desoxymannonojirimycin, verfahren zu deren herstellung und deren verwendung in arzneimitteln

Also Published As

Publication number Publication date
EP0500905A1 (en) 1992-09-02
AU638869B2 (en) 1993-07-08
US5089508A (en) 1992-02-18
DK0500905T3 (da) 1996-08-05
DE69117923D1 (de) 1996-04-18
ES2084181T3 (es) 1996-05-01
ZA916977B (en) 1992-06-24
DE69117923T2 (de) 1996-08-01
AU8539791A (en) 1992-03-30
WO1992004027A1 (en) 1992-03-19
SG81889A1 (en) 2001-07-24
EP0500905B1 (en) 1996-03-13
ATE135217T1 (de) 1996-03-15

Similar Documents

Publication Publication Date Title
BR9609063A (pt) Dinucleotídeos úteis para o tratamento de doenças pulmonares
MX9604020A (es) Arilalquildiazinonas.
MY123354A (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
DE69327642D1 (de) Verfahren zur behandlung von viralen infectionen
HU9303000D0 (en) Aryl-morpholine-derivatives and pharmaceutical compositions containing it and process for production thereof
GR3019970T3 (en) Pharmaceutical compositions for use in treating aids
EP0457090A3 (en) Process for the preparation of 3-amino-2 (het)aroyl-acrylic acid derivatives
ES2104938T3 (es) Metodo de inhibir la fibrosis.
NO933241L (no) Aminosyrer nyttige ved terapi av osteoartikulaere paavirkninger
SE9202218D0 (sv) Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
MY133438A (en) Morpholinobenzamide salts
DE69316729D1 (de) Zusammensetzungen und verfahren zur behandlung von autoimmunkrankheiten
DE3660764D1 (en) Triazole derivatives, process for their preparation and pharmaceutical compositions containing them
GR3021765T3 (en) Aminoalkylchomones, process for their preparation and pharmaceutical compositions containing them.
ES2005778A6 (es) Procedimiento para la obtencion de derivados de diisobutilxantina.
ZA933942B (en) Pyrrolothienopyrazine compounds, processes for the preparation thereof and pharmaceutical compositions containing them